Genencor Named One of the Bay Area's 100 Best Places to Work
11 Abril 2005 - 8:01AM
PR Newswire (US)
Genencor Named One of the Bay Area's 100 Best Places to Work PALO
ALTO, Calif., April 11 /PRNewswire-FirstCall/ -- Genencor
International, Inc. (NASDAQ:GCOR) announced today that it was named
one of the Bay Area's 100 Best Places to Work, a program sponsored
by the San Francisco Business Times, Silicon Valley/San Jose
Business Journal and Deloitte. Genencor was highlighted for its
"work hard, play hard" workplace environment that has resulted in a
turnover rate, which is significantly lower than biotechnology
firms in the area. "We are honored to be part of this list for the
second straight year," said Richard Ranieri, Genencor's Senior Vice
President of Human Resources. "This recognition from an outside
program is very gratifying because it is based on feedback from our
employees. This underscores Genencor's commitment to our employees
for their key role in our success." About Genencor Genencor
International, Inc. (http://www.genencor.com/) is a diversified
biotechnology company that develops and delivers innovative
products and services into the health care, agri-processing,
industrial and consumer markets. Using an integrated set of
technology platforms, Genencor's products deliver innovative and
sustainable solutions to improve the quality of life. Genencor
traces its history to 1982 and has grown to become a leading
biotechnology company, with over $410 million in year 2004 annual
revenues. Genencor has principal offices in Palo Alto, California;
Rochester, New York; and Leiden, the Netherlands. DATASOURCE:
Genencor International, Inc. CONTACT: Valerie Tucker,
+1-650-846-7571, or investors, Tom Rathjen, +1-650-846-7500, both
of Genencor Web site: http://www.genencor.com/
Copyright
Genencor International (NASDAQ:GCOR)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Genencor International (NASDAQ:GCOR)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
Real-Time news about Genencor International, (MM) (NASDAQ): 0 recent articles
Más de Genencor International, (MM) Artículos de Noticias